FRS Pioneer
|
Across tested immortalised cell lines, FRS™ Pioneer supports:
|
Datasheets
These datasheets summarise validated performance of FRS Pioneer across common use cases. Results reflect external testing under defined conditions and should be interpreted in the context of your system.
|
|
Cell types and use cases
FRS Pioneer has been evaluated primarily on:
|
User information and application notes
Detailed guidance for implementing FRS™ Pioneer in standard laboratory workflows.
|
Usage and regulatory information
- FRS™ Pioneer is supplied for research use or further manufacturing. It is not intended for diagnostic or clinical use.
- Safety Data Sheet (SDS): Chemical safety, handling, storage, and disposal information.
- Sales agreement: Media City Scientific terms of sale.
GECKO
GECKO is a chemically defined, animal component–free surface coating designed to support attachment of many adherent cell types to standard tissue culture plastic.
It is intended for use with serum-free or chemically defined media, including FRS™ Pioneer, where adhesion is not provided by serum-derived components.
It is intended for use with serum-free or chemically defined media, including FRS™ Pioneer, where adhesion is not provided by serum-derived components.
|
What GECKO™ is
GECKO™ is a defined mixture of solubilised adhesion-associated proteins commonly present in FBS, formulated as a ready-to-use surface coating. GECKO™:
High level cell line guidance
Attachment performance is cell-type dependent. FRS Pioneer is compatible with standard coatings you may already be using for your cells (e.g. laminin, collagen, gelatine, matrigel). If you typically culture cells in FBS with no coating, you may:
To achieve a fully animal-component-free workflow, either GECKO or recombinant vitronectin alone is typically effective. A first pass recommendation is provided below but please reach out for personalised support. |
What GECKO™ is not
GECKO™ is not:
In these cases, GECKO™ may be suboptimal or inappropriate. This is expected for any defined coating system. Usage and regulatory information
|
|
GECKO (fibronectin-heavy)
Non-cancer epithelial (CHO, HEK) Low TGFb cancer (MCF7) Mesenchymal (NIH-3T3) Glioblastoma (U87, A172) Renal carcinoma (ACHN) Muscle (C2C12) Skin (B16-F10) |
Vitronectin alone
High TGFb cancer (A549, H460, SW480, DU145) Hepatocyte (Hep2G) Normal kidney (MDCK) Adenocarcinoma (HT-29) |
Need help interpreting the data?
If you are unsure how the data applies to your system, optional technical support is available to help you assess fit before or after purchase.
If you are unsure how the data applies to your system, optional technical support is available to help you assess fit before or after purchase.